PCI Pharma Services, the Northeast Philadelphia-based contract development and manufacturing company has received a ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

West Pharmaceutical Services Inc. (NYSE: WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays ...

Shares of West Pharmaceutical Services Inc. slipped 4.83% to $210.89 Friday, on what proved to be an all-around dismal ...

Integrated, tech-forward platforms are going to define the next chapter of healthcare commercialization, and this merger puts ...

West Pharmaceutical Services, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – WST ...

Coriolis Pharma is investing $10 million to establish a research lab in Morrisville, North Carolina, creating 50 new jobs and ...

Investing in pharma services is also a way for healthcare-focused PE firms to invest in the pharmaceutical sector without taking on science risk or single-product risk, EQT’s Liu said.

Item 1 of 6 People visit PCI Pharma Services stand during the Convention on Pharmaceutical Ingredients (CPHI), in Barcelona, Spain, October 24, 2023.

Last fall, when the pharmaceutical services sector converged on Frankfurt, Germany, for the CPhI Worldwide drug ingredient trade show, the refrain had become rather monotonous. It was another year ...

As new advances emerge, companies in this space cannot simply ride the wave of the tech-fueled supply chain revolution; they must stay ahead of it.